SUBSCRIBE
SUBSCRIBE

Foresee Pharmaceuticals

IN THE PRESS
Foresee Pharmaceuticals Announces First Subject Dosed in its First-in-Human Clinical Trial of FP-020
April 30, 2024
 · 
3 min read
Foresee Pharmaceuticals Announces Poster Presentation and Participation at the 2024 American Thoracic Society International Conference
April 29, 2024
 · 
7 min read
Drug Development
Foresee Pharmaceuticals Receives Positive Recommendation from DSMB to Continue the Casppian Study, a Phase 3 Clinical Trial of Leuprolide (FP-001) Injectable Emulsion for the Treatment of Central Precocious Puberty
April 1, 2024
 · 
4 min read
Foresee Pharmaceuticals to Present at the American Heart Association Annual Meeting Focusing on its ALDH2 activator FP-045 in Pulmonary Hypertension Associated with Interstitial Lung Disease
October 30, 2023
 · 
5 min read
Drug Development
Foresee Pharmaceuticals Announces First Patient Dosed in the Casppian, Phase 3 Clinical Trial of Leuprolide (FP-001) injectable emulsion, 42 mg for the treatment of Central Precocious Puberty patients.
October 13, 2023
 · 
4 min read
Drug Development
Foresee Pharmaceuticals to Present Phase 1/2 Fanconi Anemia Clinical Study Design for its ALDH2 activator FP-045 at the Fanconi Anemia Research Fund 2023 Scientific Symposium
September 30, 2023
 · 
4 min read
Drug Development
Foresee Pharmaceuticals Announces Publication of Preclinical Data in Nature Communications Demonstrating the Therapeutic Potential of ALDH2 Activator AD-9308 in the Treatment of Obesity and Metabolic Syndrome-Related Disorders
September 29, 2023
 · 
5 min read
Foresee Pharmaceuticals Presents Data From its Aderamastat Program at The European Respiratory Society (ERS) International Congress 2023
September 11, 2023
 · 
4 min read
Foresee Pharmaceuticals Announces FDA Orange Book Listing of New U.S. Patent for CAMCEVI®, Extending Patent Protection to 2039
August 29, 2023
 · 
2 min read
Drug Development
Foresee Pharmaceuticals Selected for Late-Breaking Oral Presentation on its Aderamastat Phase 2 Study Results at the European Respiratory Society (ERS) International Congress 2023
July 25, 2023
 · 
4 min read
Load More
JOBS